The white paper is the culmination of a task force created by the two societies to identify opportunities for endoscopic treatments. The paper looks at endoscopic bariatric therapy treatment classification, potential indications and primary and secondary efficacy measures such as weight loss, changes in quality of life and government and industry relations. The white paper is available online in the peer-reviewed journals of both the organizations.
Related Articles on Endoscopy:
Global Gastrointestinal Endoscopy Devices Market to Reach $6.4B by 2017
6 Recommendations to Prevent Cross-Contamination in Endoscope Processing
Steris Launches Product Line for Endoscope Reprocessing
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.